Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BYAdvanced Science

ZMIZ2–DUX4–LGR5 Signaling Axis Maintains Stemness Properties and Facilitates Docetaxel Resistance in Triple‐Negative Breast Cancer

5 affiliations
  1. 1the First Hospital and College of Basic Medical Sciences of China Medical University
  2. 2Tianjin Medical University General Hospital
  3. 3Shengjing Hospital of China Medical University
  4. 4First Hospital of China Medical University
  5. 5the First Hospital of China Medical University

Related

  1. Baicalein Synergizes with Docetaxel in TNBC and the Combination Suppresses AKT/GSK3β/β-Catenin Signaling
    Taomei Yang, Xiangyun Chen, Chunwei Chu +1
    Current issues in molecular biologyPeer-reviewedCC BYFull textEurope PMC
  2. IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer
    Róża K. Przanowska, Jacky Gomez-Villa, Victoria J. Liu +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  3. HDAC6 inhibition reverts docetaxel resistance in castration resistant prostate cancer
    Ipek Bulut, Buse Cevatemre, Busra Yildirim +11
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  4. PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation
    Xinming Yin, Jiamin Zhou, Shijie Zhao +9
    iSciencePeer-reviewedCC BY-NC-ND 4.0Molecular biology & gene regulationCell biologyCell PressCrossref
  5. TMEM55B Maintains Lysosomal Homeostasis and Promotes ER–Lysosome Calcium Signaling
    Nagi Mukae, Honoka Maki, Michiko Shirane
    Traffic (Copenhagen, Denmark)Peer-reviewedCC BY-NC 4.0Full textCell biologyPMCEurope PMC
BibTeX
@article{gan2026zmiz2dux4lgr5,
  title = {{ZMIZ2–DUX4–LGR5 Signaling Axis Maintains Stemness Properties and Facilitates Docetaxel Resistance in Triple‐Negative Breast Cancer}},
  author = {Xueting Gan and Shulei Sun and Ran Hu and Yuheng Feng and Xinhao Wu and Fangqi Liu and Xuyong Lin and Xiupeng Zhang and Xuezhu Rong and Qiang Han},
  journal = {Advanced Science},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13691226},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - ZMIZ2–DUX4–LGR5 Signaling Axis Maintains Stemness Properties and Facilitates Docetaxel Resistance in Triple‐Negative Breast Cancer
AU  - Xueting Gan
AU  - Shulei Sun
AU  - Ran Hu
AU  - Yuheng Feng
AU  - Xinhao Wu
AU  - Fangqi Liu
AU  - Xuyong Lin
AU  - Xiupeng Zhang
AU  - Xuezhu Rong
AU  - Qiang Han
PY  - 2026
DA  - 2026/10/22
JO  - Advanced Science
UR  - https://europepmc.org/article/PMC/PMC13691226
SN  - 2198-3844
ER  -